Abbott Strengthens Global Diagnostics Leadership Through $21 Billion Acquisition of Exact Sciences and Strategic Expansion into Early Cancer Detection
The landscape of global oncology and medical diagnostics underwent a seismic shift this year as Abbott completed its $21 billion…
